Rehabilitation Medicine Department, The Affiliated Hospital of Southwest Medical University, Luzhou, Sichuan, People's Republic of China.
Rehabilitation Medicine, Southwest Meical University, Luzhou, People's Republic of China.
Arch Osteoporos. 2020 Aug 17;15(1):130. doi: 10.1007/s11657-020-00795-4.
Asian countries have made great progress in the osteoporosis research over the past 20 years. Mainland China has a significant increase in the number of articles. The scientific influence of Japan ranked by citations was leading in Asia. Indian researchers published fewer articles on osteoporosis, but the overall citation was quite well.
To analyze the quantity and quality of literature regarding osteoporosis from the Asian countries/regions.
Data were obtained from the Web of Science (WoS) Core Collection on May 4, 2020. Qualitative and quantitative analysis was conducted based on WoS. Keywords analysis was performed using VosView software.
The core countries/regions in Asia in the osteoporosis research included the Mainland China (MC), Japan, South Korea, Turkey, Taiwan, India, and Iran. The core countries/regions published 4798 papers, which accounted for 33.8% of the total globally. The MC with 2242 literature and Japan with 971 were ranked second and fourth worldwide. Over the past decade, MC has published the most articles and increased dramatically. Japan had the highest mean citations and the highest mean citation density. The country with the most publications in the top ten popular osteoporosis-related journals was Japan. The top institutional from the MC, Taiwan, South Korea, and Japan published the most articles. The top authors with the most articles were from Japan and MC. Top institutions and authors from Japan, MC, and India led the way in citations. The core countries/regions had more frequent cooperation with the USA, the UK, and Canada compared with the limited cooperation among Asian countries. Osteoporosis research in Asia relies heavily on public funding and pharmaceutical companies. Keywords for these studies have changed over the past 20 years.
Asian countries have made progress in the osteoporosis research over the past 20 years. The MC has a significant increase in the number of articles. The scientific influence of Japan ranked by citations was leading in Asia. Indian researchers published fewer articles on osteoporosis, but the overall quality was quite well. The core Asian countries/regions should strengthen in-depth cooperation in the future.
在过去的 20 年中，亚洲国家在骨质疏松症研究方面取得了巨大进展。中国大陆的文章数量显著增加。日本的引文科学影响力在亚洲处于领先地位。印度研究人员发表的骨质疏松症相关文章较少，但总体引文情况相当不错。
分析亚洲国家/地区骨质疏松症文献的数量和质量。
数据于 2020 年 5 月 4 日从 Web of Science（WoS）核心合集获取。基于 WoS 进行定性和定量分析。关键词分析使用 VosView 软件进行。
亚洲骨质疏松症研究的核心国家/地区包括中国大陆（MC）、日本、韩国、土耳其、中国台湾、印度和伊朗。核心国家/地区发表了 4798 篇论文，占全球总数的 33.8%。MC 以 2242 篇文献和日本的 971 篇文献分别位居全球第二和第四。在过去十年中，MC 发表的文章最多且增长迅猛。日本的平均被引频次最高，平均被引密度最高。在十大热门骨质疏松相关期刊中发文最多的国家是日本。来自 MC、中国台湾、韩国和日本的顶尖机构发表的文章最多。发文量最多的作者来自日本和 MC。来自日本、MC 和印度的顶尖机构和作者在引文方面处于领先地位。与亚洲国家之间有限的合作相比，亚洲核心国家/地区与美国、英国和加拿大的合作更加频繁。亚洲的骨质疏松症研究主要依赖公共资金和制药公司。过去 20 年来，这些研究的关键词发生了变化。
在过去的 20 年中，亚洲国家在骨质疏松症研究方面取得了进展。MC 的文章数量显著增加。日本的引文科学影响力在亚洲处于领先地位。印度研究人员发表的骨质疏松症相关文章较少，但总体质量相当不错。未来，亚洲核心国家/地区应加强深入合作。
